Ligand validation:7JIR

MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7JIR_MES_A_510	16%	64%	0.239	0.805	0.9	0.48	-	-	0	0	100%	1
7JIW_MES_A_510	62%	66%	0.157	0.952	0.84	0.45	-	-	0	0	100%	1
7JIT_MES_A_509	52%	52%	0.151	0.91	0.91	0.98	-	2	0	0	100%	0.8
7KOL_MES_A_510	50%	61%	0.185	0.939	0.88	0.59	-	-	0	0	100%	1
7JIV_MES_A_506	21%	59%	0.219	0.828	0.83	0.74	-	1	0	0	100%	1
7KOK_MES_A_510	19%	65%	0.201	0.793	0.73	0.61	-	-	0	0	100%	0.8
8AJQ_MES_H_201	100%	40%	0.037	0.992	1.52	0.93	1	1	0	0	100%	1
4NWT_MES_L_301	100%	26%	0.045	0.99	1.24	1.94	2	4	0	0	100%	1
4S23_MES_B_502	100%	24%	0.05	0.993	1.97	1.34	1	1	0	0	100%	1
5NJ9_MES_A_502	99%	62%	0.049	0.988	0.71	0.74	-	1	0	0	100%	1
4S38_MES_A_902	99%	54%	0.057	0.987	0.82	0.95	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.